GlassScriptPhysician profile
Andrew J Grossbach
NPI 1033439047
$212,929.71
in general payments reported to CMS, 2019-2025
23 companies · $56K in 2025
The $56K reported for 2025 was more than what 95% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,076 · 2020: $2,051 · 2021: $27K · 2022: $42K · 2023: $25K · 2024: $54K · 2025: $56K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $57K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $44K · Travel and Lodging: $24K · Food and Beverage: $9,975.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $56,664.25 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $43,933.50 |
| Travel and Lodging | $23,972.98 |
| Food and Beverage | $9,975.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $156,346.50 | 2021-2025 | Unid_pass, Mazor X System, Infinity Occipitocervical Upper Thoracic System |
| Kuros Biosciences USA, INC | $16,224.41 | 2025 | Magnetos |
| Depuy Synthes Products, INC. | $9,426.26 | 2021-2022 | |
| Kci USA, INC. | $7,582.98 | 2021-2023 | Prevena, 3m Cavilon, Activ.A.C. |
| Depuy Synthes Sales INC. | $7,041.91 | 2020-2025 | Velys |
| Medical Device Business Services, INC. | $5,075.73 | 2019-2025 | Velys, Expedium, Conduit |
| Medtronic USA, INC. | $4,497.82 | 2019-2020 | |
| Globus Medical, INC. | $2,173.43 | 2019-2025 | Reline, Mars 3v/3vl, Creo Threaded |
| Solventum Corporation | $1,406.25 | 2024 | 3m Ioban, Prevena Restor Axioform, Prevena Restor Bellaform |
| Nuvasive, INC. | $898.22 | 2019-2023 | Xlif, Pulse, Reline |
| Alphatec Spine, INC | $649.30 | 2019-2020 | |
| Arteriocyte Medical Systems, INC. | $421.96 | 2023-2025 | Magellan |
| Orthofix Medical, INC. | $371.10 | 2020-2021 | |
| Spinal Elements, INC. | $253.67 | 2022 | |
| Augmedics INC. | $128.03 | 2023 | Xvision |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cerapedics INC. | $85.41 | 2021 | |
| Penumbra, INC. | $78.98 | 2024 | Penumbra System |
| Stryker Corporation | $76.40 | 2025 | Universal Neuro 3 |
| Clearpoint Neuro, INC. | $68.11 | 2023 | Clearpoint |
| Aesculap, INC. | $63.17 | 2023 | Progav 2.0 |
| Intrinsic Therapeutics | $52.99 | 2025 | Barricaid Acd (Annular Closure Device) |
| Ulrich Medical USA, INC. | $7.08 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Grossbach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.